AI Drug Discovery Biz Valued At $3.8B After Series C Round
By Jade Martinez-Pogue · July 14, 2026, 4:07 PM EDT
Artificial intelligence-based drug discovery company Chai Discovery on Tuesday revealed that it reached a $3.8 billion valuation after closing its latest funding round with $400 million in tow....
To view the full article, register now.